Honorary Chairman
Danny Naveh – Minister of Health, State of Israel

Israel Chairmen
Israel Makov – President and CEO, TEVA Pharmaceuticals
Michael Sela – Institute Professor of Immunology, Deputy Chairman of the Board of Governors and President Emeritus, The Weizmann Institute of Science

United States Chairmen
Frederick Frank – Vice Chairman, Lehman Brothers
Jonathan C. Javitt, M.D., M.P.H. – Vice Chairman of Health Directions, LLC and Chair of the Health Subcommittee for the President’s Information Technology Advisory Committee (PITAC)
Leonard Schleifer, M.D., Ph.D. – CEO & President, Regeneron Pharmaceuticals

Israeli Board of Advisors
Haim Aviv, Ph.D. – Chairman and CEO, Pharmos
Yehuda Baruch – Ministry of Health Acting Director of Medical Administration, State of Israel
Shlomo Ben-Haim, M.D., D.Sc. – Impulse Dynamics
Rafael Beyar, M.D., D.Sc. – Dean, Technion: Israel Institute of Technology, Bruce Rappaport Faculty of Medicine
Neil Cohen – Partner, Israel Seed Partners
Rafi Hofstein, Ph.D. – President and CEO, Hadasit
Morris C. Laster, M.D. – CEO, BioLineRx Ltd.
Jonathon Medved – Partner, Israel Seed Partners
Avi Molcho, M.D. – Managing Director, Life Sciences; Giza Venture Capital
Arie Orenstein, M.D. – Director of Advanced Technology Center, The Chaim Sheba Medical Center
Aharon Schwartz, Ph.D. – Vice President of Business Planning & New Ventures, Teva Pharmaceuticals
Benjamin Zeevi, M.D. — General Partner, Tamir Fishman Ventures

United States Board of Advisors
Avraham (Barry) Cohen – Chairman, Chugai Pharma USA
Elliot Hahn, Ph.D. – Chairman, Andrx
Jonathan Leff – Biotech Analyst, Warburg Pincus
Lewis C. Pell – Co-founder and Vice Chairman of the Board, Vision Sciences

Speakers and Attendees
Kenneth S. Abramowitz – Managing General Partner, New Global Network (NGN) Capital
Isaac Applbaum – Partner, Lightspeed Venture Partners
Alan H. Auerbach – Chief Executive Officer/President, Cougar Biotechnology, Inc.
Haim Aviv, Ph.D. – Chairman and CEO, Pharmos
Thomas R. Baruch – General Partner, CMEA Ventures
Yehuda Baruch – Ministry of Health Acting Director of Medical Administration, State of Israel
Shlomo Ben-Haim, M.D., D.Sc. – Professor, Impulse Dynamics
Carole S. Ben-Maimon, M.D. — President and COO, Barr Research
Rafael Beyar, M.D., D.Sc. – Dean, Technion: Israel Institute of Technology, Bruce Rappaport Faculty of Medicine
Leonard M. Blum – Vice President of Sales and Marketing, ICOS Corporation
Robert Blum – EVP of Corporate Development and Finance and CFO, Cytokinetics, Inc.
Benjamin R. Bowen, Ph.D. – Director of Investment Banking, Rodman and Renshaw
Ronald Brandt – Interim CEO and President, Chiral Quest
Gerald Chan, Ph.D. – Co-Founder, The Morningside Technology Group
Neil Cohen – Partner, Israel Seed Partners
Francis S. Collins, M.D., Ph.D. – Director, National Human Genome Research Institute
Elazer R. Edelman, M.D., Ph.D. – Director of the Harvard-MIT Biomedical Engineering Center in the Harvard-MIT Division of Health Sciences and Technology
Richard A. Edlin - Shareholder, Greenberg Traurig LLP
Leonard Firestone, M.D. – Chief Executive Officer and President, Manhattan Pharmaceuticals, Inc.
Frederick Frank – Vice Chairman, Lehman Brothers
Mara Goldstein – Executive Director, CIBC World Markets
Scott Gottlieb – Centers for Medicare and Medicaid Services (CMS)
Robert L. Grossman – Shareholder, Greenberg Traurig
William A. Haseltine, Ph.D. – Chairman and CEO, Human Genome Sciences
Victor M. Hermelin – Chairman, KV Pharmaceutical Company
Malcolm Hoenlein - Executive Vice Chairman, Conference of Presidents of Major American Jewish Organizations
Rafi Hofstein, Ph.D. – President and CEO, Hadasit
Jonathan C. Javitt, M.D., M.P.H. – Vice Chairman of Health Directions, LLC and Chair of the Health Subcommittee for the President’s Information Technology Advisory Committee (PITAC)
Joshua Kazam - Managing Director, Paramount Capital, Inc.
Morris C. Laster, M.D. – CEO, BioLineRx Ltd.
Martin Leon, M.D., Ph.D. – President & CEO, Cardiovascular Research Foundation, Lenox Hill Heart & Vascular Institute
Jonathan Lewis, M.D., Ph.D. – CEO, President & Chairman, Ziopharm, Inc.
Israel Makov – President and CEO, TEVA Pharmaceuticals
Alfred Mann – Chairman and Co-Chief Executive Officer, Advanced Bionics
Mark McClellan, M.D., Ph.D. – Administrator for the Centers for Medicare and Medicaid Services (CMS) and Former Commissioner of the Food & Drug Administration (FDA)
Jonathon Medved – Partner, Israel Seed Partners
Avi Molcho, M.D. – Managing Director, Life Sciences; Giza Venture Capital
Dan Naveh – Minister of Health, State of Israel
Arie Orenstein, M.D. – Director of Advanced Technology Center, The Chaim Sheba Medical Center
Lewis C. Pell – Co-founder and Vice Chairman of the Board, Vision Sciences
Elemer Piros, Ph.D. – Senior Biotechnology Analyst, Rodman and Renshaw
Zvi Raviv – Director General, The New Jerusalem Foundation
Mary-Lacey Reuther – Special Assistant to the Administrator, Centers for Medicare and Medicaid Services (CMS)
Leonard Schleifer, M.D., Ph.D. – CEO & President, Regeneron Pharmaceuticals
Aharon Schwartz, Ph.D. – Vice President of Business Planning & New Ventures, Teva Pharmaceuticals
Michael Sela –Institute Professor of Immunology, Deputy Chairman of the Board of Governors and President Emeritus, The Weizmann Institute of Science
Gary Shangold, M.D. – President and CEO, NovaDel Pharma
Mark J. Simon – Managing Director and Head of Biotechnology, Citigroup
Daniel Troy – Chief General Counsel, Food and Drug Administration
Michael Vasinkevich – Senior Managing Director, Rodman & Renshaw
Harlan F. Weisman, M.D. – President, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Todd Wider, M.D. – Plastic Surgeon
Benjamin Zeevi, M.D. — General Partner, Tamir Fishman Ventures

Back to Top